Steroid Injection in Idiopathic Granulomatous Mastitis

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorAssiut University

About this trial

Granulomatous mastitis (GM) is a non-infectious inflammatory breast condition typically affecting young women, often following breastfeeding. Management of GM often begins with anti-inflammatory medications and antibiotics. Steroids, particularly intralesional corticosteroids, are considered the first-line treatment for GM due to their rapid anti-inflammatory and immunosuppressive effects. Steroids help control symptoms such as painful lumps, swelling, and redness. Steroids' effectiveness in providing symptom relief minimizes the need for more invasive treatments such as surgery.

Eligibility criteria

Qualifiers

Women diagnosed with IGM confirmed clinically and histopathologically , willing to undergo intralesional steroid treatment.

Disqualifiers

Patients with active infections.

Patients on immunosuppressive therapy.

pregnant women.

Trial design

Treatments tested in this trial

  • Ultrasound guided intralesional Steroids injection (Triamicinolone)

Treatment groups

40 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators